Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • AV Rheum
    • Forum
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Publisher Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Publisher Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • AV Rheum
    • Forum
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
Research ArticleArticle

The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population

Hubertina J.M.J. Crijns, Janneke Jentink, Ester Garne, Christine C. Gispen-de Wied, Sabine M.J.M. Straus and Lolkje T.W. de Jong-van den Berg
The Journal of Rheumatology July 2011, jrheum.101316; DOI: https://doi.org/10.3899/jrheum.101316
Hubertina J.M.J. Crijns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janneke Jentink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ester Garne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine C. Gispen-de Wied
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine M.J.M. Straus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lolkje T.W. de Jong-van den Berg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
Next
Loading

Article Information

jrheum.101316
DOI 
https://doi.org/10.3899/jrheum.101316
PubMed 
21724702

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online July 1, 2011.

Article Versions

  • You are currently viewing a Latest version of this article (July 1, 2011 - 04:00).
  • View the most recent version of this article
Copyright & Usage 
© 2011 The Journal of Rheumatology

Author Information

  1. Hubertina J.M.J. Crijns,
  2. Janneke Jentink,
  3. Ester Garne,
  4. Christine C. Gispen-de Wied,
  5. Sabine M.J.M. Straus and
  6. Lolkje T.W. de Jong-van den Berg; for the EUROCAT Working Group
  1. From the Medicines Evaluation Board, The Hague, The Netherlands; Department of PharmacoEpidemiology and PharmacoEconomics, University of Groningen, Groningen, The Netherlands; Paediatric Department, Lillebaelt Hospital, Kolding, Denmark; and Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
    H.J.M.J. Crijns, MD, Medicines Evaluation Board; J. Jentink, MSc, Department of PharmacoEpidemiology and PharmacoEconomics, University of Groningen; E. Garne, MD, PhD, Paediatric Department, Lillebaelt Hospital; C.C. Gispen-de Wied, PhD; S.M.J.M. Straus, MD, PhD, Medicines Evaluation Board, Erasmus Medical Centre, Rotterdam; L.T.W. de Jong-van den Berg, RPh, PhD, Department of PharmacoEpidemiology and PharmacoEconomics, SHARE Graduate School, University of Groningen.
    Address correspondence to Prof. L.T.W. de Jong-van den Berg, Department of PharmacoEpidemiology and PharmacoEconomics, University of Groningen, Ant Deusinglaan 1, 9713 AV Groningen, The Netherlands. E-mail: l.t.w.de.jong-van.den.berg@rug.
    Accepted for publication April 28, 2011.

Article usage

Article usage: June 2011 to January 2019

AbstractFullPdf
Jun 2011101
Jul 2011160016
Aug 201187188
Sep 2011756858
Oct 2011165313
Nov 20118236
Dec 201190611
Jan 20128126
Feb 20124734
Mar 20123944
Apr 20123422
May 20125835
Jun 20122747
Jul 20124823
Aug 20122531
Sep 20122423
Oct 20123866
Nov 201233612
Dec 20123634
Jan 20135225
Feb 20134613
Mar 20133448
Apr 20131912
May 20132315
Jun 20131133
Jul 20131914
Aug 20131010
Sep 20131912
Oct 20131746
Nov 2013912
Dec 20131842
Jan 20142214
Feb 20141112
Mar 20141123
Apr 20141100
May 20141244
Jun 2014831
Jul 2014802
Aug 2014323
Sep 20141802
Oct 20141000
Nov 20141000
Dec 2014212
Jan 20152033
Feb 20152223
Mar 2015832
Apr 2015812
May 2015400
Jun 20151510
Jul 2015411
Aug 2015911
Sep 2015743
Oct 20152822
Nov 20151213
Dec 20151121
Jan 20161822
Feb 20161712
Mar 20161021
Apr 20161812
May 20161703
Jun 2016911
Jul 20161222
Aug 20161801
Sep 20161011
Oct 20161530
Nov 20162402
Dec 20163936
Jan 20172532
Feb 20172001
Mar 20171811
Apr 20171600
May 20171600
Jun 2017911
Jul 20171223
Aug 2017800
Sep 20172611
Oct 20171110
Nov 20172232
Dec 20175232
Jan 20184111
Feb 20184724
Mar 20185511
Apr 20183311
May 20182911
Jun 20181432
Jul 20181753
Aug 20181731
Sep 20181300
Oct 20181434
Nov 20181600
Dec 2018900
Jan 20192401

Next
Back to top

In this issue

The Journal of Rheumatology: 46 (2)
The Journal of Rheumatology
Vol. 46, Issue 2
1 Feb 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
Citation Tools
The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population
Hubertina J.M.J. Crijns, Janneke Jentink, Ester Garne, Christine C. Gispen-de Wied, Sabine M.J.M. Straus, Lolkje T.W. de Jong-van den Berg
The Journal of Rheumatology Jul 2011, jrheum.101316; DOI: 10.3899/jrheum.101316

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population
Hubertina J.M.J. Crijns, Janneke Jentink, Ester Garne, Christine C. Gispen-de Wied, Sabine M.J.M. Straus, Lolkje T.W. de Jong-van den Berg
The Journal of Rheumatology Jul 2011, jrheum.101316; DOI: 10.3899/jrheum.101316
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions
  • Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
  • Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • AV Rheum
  • Forum

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Company Limited
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire